Sagent Pharmaceuticals Inc
Complete recall history across all FDA and CPSC categories — 16 total recalls
Sagent Pharmaceuticals Inc appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (16)
FDA drug safety enforcement actions by Sagent Pharmaceuticals Inc
| Date | Product | Reason | Class |
|---|---|---|---|
| May 19, 2023 | Nafcillin for Injection, USP, 1 gram per vial, Rx only, Mfd. for SAGENT Pharm... | Lack of Assurance of Sterility | Class II |
| May 19, 2023 | Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharm... | Lack of Assurance of Sterility | Class II |
| May 19, 2023 | Nafcillin for Injection, USP, 10 gram per Pharmacy Bulk Package, Rx only, Mfd... | Lack of Assurance of Sterility | Class II |
| Feb 28, 2023 | Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose ... | Labeling: Not elsewhere classified | Class II |
| Mar 11, 2021 | Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial pac... | Lack of Assurance of Sterility: customer complaints of loose crimped vial ove... | Class II |
| Apr 30, 2019 | Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL V... | Lack of Sterility Assurance: Microbial growth detected during a routine simul... | Class II |
| Mar 5, 2018 | methylPREDNISolone Sodium Succinate for Injection, USP, 125 mg* per vial, Sin... | Failed Impurities/Degradation Specifications: High out of specification resul... | Class II |
| Mar 5, 2018 | methylPREDNISolone Sodium Succinate for Injection, USP, 1 gram* per vial, Sin... | Failed Impurities/Degradation Specifications: High out of specification resul... | Class II |
| Mar 5, 2018 | methylPREDNISolone Sodium Succinate for Injection, USP, 40 mg* per vial, Sing... | Failed Impurities/Degradation Specifications: High out of specification resul... | Class II |
| Jun 13, 2016 | Oxacillin for Injection, USP, 10 grams per pharmacy bulk package, Buffered - ... | Presence of Particulate Matter; The firm received two product complaints for ... | Class II |
| Mar 1, 2016 | Fluconazole Injection, USP (in 0.9% Sodium Chloride), 200 mg per 100 ml, Sing... | Cross contamination with other products: metronidazole | Class II |
| Feb 23, 2015 | Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5... | Lack of Assurance of Sterility: Recall initiated due to FDA observations pert... | Class II |
| Feb 23, 2015 | Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only,... | Lack of Assurance of Sterility: Recall initiated due to FDA observations pert... | Class II |
| Oct 3, 2014 | Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-... | Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, ... | Class II |
| Mar 4, 2014 | Zoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL), 100 mL single-use bag... | Lack of Assurance of Sterility; leaking of premix bags | Class II |
| Jun 7, 2013 | VECURONIUM Bromide for Injection, 10 mg* per vial, *1 mg per mL when reconsti... | CGMP Deviations: product was not manufactured under current good manufacturin... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.